GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (NAS:MLAB) » Definitions » Cash-to-Debt

Mesa Laboratories (Mesa Laboratories) Cash-to-Debt : 0.12 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Mesa Laboratories Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Mesa Laboratories's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.12.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Mesa Laboratories couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Mesa Laboratories's Cash-to-Debt or its related term are showing as below:

MLAB' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05   Med: 0.18   Max: 1.8
Current: 0.12

During the past 13 years, Mesa Laboratories's highest Cash to Debt Ratio was 1.80. The lowest was 0.05. And the median was 0.18.

MLAB's Cash-to-Debt is ranked worse than
93.44% of 2470 companies
in the Hardware industry
Industry Median: 1.38 vs MLAB: 0.12

Mesa Laboratories Cash-to-Debt Historical Data

The historical data trend for Mesa Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Mesa Laboratories Cash-to-Debt Chart

Mesa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 0.58 1.80 0.22 0.18

Mesa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.18 0.18 0.21 0.12

Competitive Comparison of Mesa Laboratories's Cash-to-Debt

For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesa Laboratories's Cash-to-Debt Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Mesa Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Mesa Laboratories's Cash-to-Debt falls into.



Mesa Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Mesa Laboratories's Cash to Debt Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Mesa Laboratories's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mesa Laboratories  (NAS:MLAB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Mesa Laboratories Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesa Laboratories (Mesa Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Executives
Brian David Archbold officer: SVP of Continuous Improvement 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John Bradley Schmieder director C/O MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Gary M Owens officer: COO 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
John V Sakys officer: VP Finance, CFO MESA LABORATORIES, INC., 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Shannon Hall director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Evan Guillemin director 380 LAFAYETTE STREET, SIXTH FLOOR, NEW YORK NY 10003
R Tony Tripeny director ONE RIVERFRONT PLAZA, CORNING NY 14831
Gregory Dinoia officer: SVP Commercial Operations 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
Mesa Laboratories Inc /co/ director 12100 W 6TH AVE, LAKEWOOD CO 80228
John James Sullivan officer: VP Sales & Marketing 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David M Kelly director
Shiraz Shabanali Ladiwala director C/O THERMO FISHER SCIENTIFIC INC., 168 THIRD AVENUE, WALTHAM MA 02451
Robert V Dwyer director 12100 W 6TH AVE, LAKEWOOD CO 80228
Jennifer Sadie Alltoft director 12100 W. 6TH AVENUE, LAKEWOOD CO 80228
David Brian Perez director 12100 6TH AVENUE, LAKEWOOD CO 80228

Mesa Laboratories (Mesa Laboratories) Headlines

From GuruFocus

MESA LABS DECLARES QUARTERLY DIVIDEND

By GuruFocusNews GuruFocusNews 01-06-2022

Mesa Labs Closes Acquisition of Agena Bioscience

By Marketwired Marketwired 10-20-2021

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

By GuruFocusNews GuruFocusNews 07-07-2022

Mesa Labs Acquires Belyntic's Peptide Purification Business

By Value_Insider Value_Insider 11-17-2022

Mesa Labs Announces First Quarter Results

By PurpleRose PurpleRose 08-04-2022

MESA LABS DECLARES QUARTERLY DIVIDEND

By Marketwired 10-03-2023

Should Investors Worry About Mesa Laboratories Inc's Insider Sells?

By GuruFocus Research GuruFocus Editor 02-10-2023